Clinical trials
Phase 2/3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 2 |
| Completed | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Roswell Park Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Lymphoma | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, T-Cell, Cutaneous | 2 |
| Mycosis Fungoides | 2 |
| Sezary Syndrome | 2 |
| Anemia, Aplastic | 1 |
| Anemia, Refractory | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 26 to 5 of 5. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.